جميع الدراسات
التوظيفعلم الأدوية البشري (المرحلة الأولى) - أخرىتداخلي

دراسة متعددة المراكز، من المرحلة 1ب، مزدوجة التعمية، محكومة بدواء وهمي لتقييم سلامة وتحمل وفعالية si-544 لدى البالغين المصابين بالصدفية الشائعة أو التهاب المفاصل الصدفي

This study is looking into a new medication called si-544 for adults who have psoriasis or psoriatic arthritis. It's a Phase 1b study, which means it's one of the first times this new medicine is being tested in a small group of people. The main goals are to see if si-544 is safe to use, if people can tolerate it well, and if it shows any signs of helping with the symptoms of these conditions. To make sure results are fair, some participants will receive the actual medicine, while others will get a placebo (a dummy treatment) without knowing which one they are getting. This helps researchers understand the true effects of si-544.

نظرة سريعة

الحالة
التوظيف
المرحلة
علم الأدوية البشري (المرحلة الأولى) - أخرى
الراعي
selectION Therapeutics GmbH
الهدف من التسجيل
45
ابدأ
07 Dec 2023

ما هو موضوع هذه الدراسة؟

This research study is focused on understanding a new medicine, si-544, and its potential for treating adults living with psoriasis or psoriatic arthritis. Psoriasis is a condition that causes red, scaly patches on the skin, while psoriatic arthritis can cause pain and swelling in the joints, as well as skin changes.

This particular study is called a 'Phase 1b' trial. This means it's an early stage of testing for a new medicine. At this stage, doctors are mainly looking to see if the medicine is safe for people to take, and if they experience any side effects. They also want to get an idea of whether the medicine shows any promise in treating the conditions it's designed for. This is a crucial step before the medicine can be tested in larger groups of people.

The study is designed so that neither the patient nor their doctor will know if they are receiving the experimental medicine (si-544) or a placebo. A placebo looks just like the real medicine but contains no active ingredients. This 'double-blind' approach helps ensure that any changes observed are truly due to the medicine being tested and not influenced by expectations. By carefully gathering information, researchers hope to learn if si-544 could be a helpful new treatment option in the future.

النقاط الرئيسية

  • This study is testing a new medicine for psoriasis and psoriatic arthritis.
  • It's an early-stage study focused on safety and early signs of effectiveness.
  • سيحصل المشاركون إما على الدواء الجديد أو على علاج وهمي.
  • It involves regular clinic visits for health checks and monitoring.
  • المشاركة طوعية، ويمكنك الانسحاب في أي وقت.
  • It's for adults aged 18 or older with these conditions.

من قد يكون مؤهلاً؟

To be considered for this study, you must be an adult aged 18 or older. The study is open to both men and women. You would need to have been diagnosed with either psoriasis vulgaris, which is a common type of psoriasis affecting the skin, or psoriatic arthritis, which affects both the skin and the joints.

There might be other specific health requirements or conditions that would mean you can't join the study, even if you have psoriasis or psoriatic arthritis and are over 18. These often relate to your overall health, other medicines you might be taking, or certain medical history. These will be discussed in detail by the study team.

The study team will carefully review your medical history and current health to make sure that taking part is safe for you and that you meet all the necessary criteria. It's important to be open and honest about your health when discussing it with them.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. هل عمرك 18 سنة أو أكثر؟
  2. Do you have a diagnosis of psoriasis vulgaris?
  3. Or do you have a diagnosis of psoriatic arthritis?
  4. Are you willing to attend regular clinic appointments?
  5. Are you able to follow study instructions carefully?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you decide to take part in this study, you would receive either the new medicine, si-544, or a dummy treatment (placebo). You wouldn't know which one you are getting. You would need to attend several visits to the study clinic over a period of time. During these visits, the study team would:

* Perform physical examinations to check your overall health. * Take blood and urine samples to monitor your body's response and check for safety. * Ask you questions about your symptoms and how you are feeling. * Check for any side effects you might be experiencing.

They may also take measurements related to your psoriasis or psoriatic arthritis to see if the treatment is having any effect. The total length of the study and how many visits are needed will be fully explained to you before you commit to joining.

المخاطر والفوائد المحتملة

Participating in this study might offer some potential benefits, such as contributing to medical science and possibly receiving a new treatment that could help your condition, although this is not guaranteed as it's an early-stage study. However, like any new medicine, si-544 may cause side effects, some of which may not yet be fully known. You might also need to attend many appointments, which can be time-consuming. You are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

المواقع (1)

بعض مواقع الأماكن تقريبية. نحن نعمل على تحسين ذلك — يرجى التحقق مع فريق التجربة قبل السفر.
  • —
    غير مؤكد
    ألمانيا

أسئلة شائعة

ما هي دراسة 'المرحلة 1ب'؟

It's an early stage of testing a new medicine. The main goals are to see if it's safe and if people can tolerate it well, and to gather very early information on whether it might help treat the condition.

ما هو الدواء الوهمي؟

A placebo is a 'dummy' treatment that looks exactly like the real medicine but contains no active ingredients. It helps researchers understand the true effects of the study drug.

من يمكنه المشاركة في هذه الدراسة؟

Adults aged 18 or over who have either psoriasis vulgaris or psoriatic arthritis may be eligible. Specific health checks will confirm if you can join.

هل سأعرف إذا كنت أحصل على الدواء الحقيقي؟

No, this is a 'double-blind' study, meaning neither you nor your doctor will know if you're receiving si-544 or the placebo until the study is over.

هل يمكنني مغادرة الدراسة إذا غيرت رأيي؟

Yes, you have the right to withdraw from the study at any time, for any reason, without affecting your current or future medical care.

كيفية معرفة المزيد

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "A multicenter, Phase 1b, double-blind, placebo-controlled st… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.